,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-08-30 07:01:00,Shares of Veeva Systems (NYSE: VEEV) rallied 12% to an all-time high on Aug. 24 after the cloud services provider reported second-quarter earnings.,0.9469348788261414,0.025915374979376793,0.02714982070028782,positive,0.9210194945335388
1,2018-08-30 07:01:00,"Veeva's revenue rose 25% annually to $209.6 million, beating estimates by $6 million and representing its strongest growth in four quarters.",0.9562540650367737,0.02225060574710369,0.02149531990289688,positive,0.934003472328186
2,2018-08-30 07:01:00,"Its non-GAAP net income grew 68% to $61.4 million, or $0.39 per share, which beat estimates by five cents.",0.9573008418083191,0.02313954383134842,0.019559577107429504,positive,0.9341613054275513
3,2018-08-30 07:01:00,"On a GAAP (unadjusted) basis, its net income rose 30% to $50.3 million, or $0.32 per share.",0.9566984176635742,0.019289733842015266,0.024011876434087753,positive,0.9374086856842041
4,2018-08-30 07:01:00,"For the third quarter, Veeva expects its revenue to rise 22%-23% annually, and for its non-GAAP EPS to grow 52%.",0.9538866281509399,0.015829937532544136,0.030283404514193535,positive,0.9380567073822021
5,2018-08-30 07:01:00,"For the full year Veeva anticipates 23% revenue growth, and for its non-GAAP earnings to rise 58%-59%.",0.9531329870223999,0.01561379712074995,0.03125325217843056,positive,0.9375191926956177
6,2018-08-30 07:01:00,All those forecasts exceeded analyst expectations.,0.38490957021713257,0.021087216213345528,0.5940032005310059,neutral,0.363822340965271
7,2018-08-30 07:01:00,"Veeva's growth prospects look rosy, but at around $100, its stock trades at 68 times this year's earnings estimate and 63 times next year's estimates.",0.35126733779907227,0.12595853209495544,0.5227741003036499,neutral,0.22530880570411682
8,2018-08-30 07:01:00,"Should investors chase Veeva at these levels, or wait for a pullback?",0.11496474593877792,0.05936518684029579,0.825670063495636,neutral,0.05559955909848213
9,2018-08-30 07:01:00,What does Veeva do?,0.03823433816432953,0.028243908658623695,0.9335217475891113,neutral,0.009990429505705833
10,2018-08-30 07:01:00,Veeva provides cloud-based services for the healthcare industry.,0.032019924372434616,0.005064029712229967,0.9629160761833191,neutral,0.026955895125865936
11,2018-08-30 07:01:00,"Its Veeva Vault helps companies track industry regulations, clinical trials, and prescribing habits on a cloud platform.",0.04829273745417595,0.009099777787923813,0.9426074624061584,neutral,0.039192959666252136
12,2018-08-30 07:01:00,Its Veeva Commercial Cloud helps drug companies maintain customer relationships through a cloud-based system.,0.22256647050380707,0.0063621364533901215,0.7710713744163513,neutral,0.21620433032512665
13,2018-08-30 07:01:00,"Veeva has strong ties with Salesforce (NYSE: CRM) , the world's top provider of cloud-based CRM (customer relationship management) solutions.",0.8430158495903015,0.011784803122282028,0.14519940316677094,positive,0.8312310576438904
14,2018-08-30 07:01:00,"Veeva founder and CEO Peter Gassner was previously Salesforce's senior vice president of technology, and Veeva's CRM platform is powered by the Salesforce1 app development platform.",0.023660004138946533,0.0057172528468072414,0.970622718334198,neutral,0.017942750826478004
15,2018-08-30 07:01:00,Veeva's services are also integrated into Salesforce's marketing and service clouds.,0.07611456513404846,0.004736505914479494,0.9191489219665527,neutral,0.07137805968523026
16,2018-08-30 07:01:00,"Salesforce also offers CRM services for the healthcare industry, but its Health Cloud doesn't directly compete against Veeva's services.",0.05315857380628586,0.04635419324040413,0.9004872441291809,neutral,0.006804380565881729
17,2018-08-30 07:01:00,Salesforce's platform generally focuses on patient care and personalized medicine instead of clinical trials and the industry needs of pharmaceutical companies.,0.021100090816617012,0.00585585692897439,0.9730440378189087,neutral,0.01524423435330391
18,2018-08-30 07:01:00,"Veeva serves over 600 customers, including pharmaceutical giants GlaxoSmithKline , Novartis , and AstraZeneca .",0.08570592850446701,0.005142921581864357,0.9091511964797974,neutral,0.0805630087852478
19,2018-08-30 07:01:00,"On the clinical trials front, it finished the quarter with over 200 Veeva Vault eTMF customers, 28 Veeva Vault CTMS customers, and 12 Vault EDC customers.",0.1647578924894333,0.009028312750160694,0.8262137770652771,neutral,0.15572957694530487
20,2018-08-30 07:01:00,"Veeva continues to expand its ecosystem with new services like Veeva Nitro, a next-gen commercial data warehouse for life science companies; the Veeva Vault Training platform to help companies with role-based training; and the Veeva CRM Sunrise UI (user interface), which lets users access the platform across multiple devices.",0.7949896454811096,0.011525962501764297,0.19348439574241638,positive,0.7834636569023132
21,2018-08-30 07:01:00,Veeva generates most of its revenue from subscriptions for its Veeva Vault and Commercial Cloud services.,0.015182140283286572,0.006982861552387476,0.9778349995613098,neutral,0.008199278265237808
22,2018-08-30 07:01:00,"It generates a smaller amount of revenue from its growing ""professional services and other"" division, which trains companies' teams in the deployment of their cloud services.",0.01653912290930748,0.02852330170571804,0.9549375772476196,neutral,-0.01198417879641056
23,2018-08-30 07:01:00,Here's how those core businesses fared during the second quarter.,0.04641026630997658,0.013066774234175682,0.9405229687690735,neutral,0.033343493938446045
24,2018-08-30 07:01:00,Veeva's total non-GAAP gross margin rose 1.5 percentage points annually to 73.7%.,0.9563527703285217,0.01877426914870739,0.02487291768193245,positive,0.9375784993171692
25,2018-08-30 07:01:00,"Its total operating expenses climbed 23% to $97.6 million, but its non-GAAP operating margin still expanded from 31.9% to 35.5%.",0.9563255906105042,0.021219871938228607,0.022454574704170227,positive,0.9351057410240173
26,2018-08-30 07:01:00,"Veeva's stock-based compensation expenses rose 47% to $19.7 million, but that only accounted for 9% of its revenues.",0.9350315928459167,0.02595260925590992,0.03901581093668938,positive,0.9090789556503296
27,2018-08-30 07:01:00,"Meanwhile, its cash and equivalents grew from $320.2 million at the beginning of 2018 to $511.7 million thanks to its stronger billings, rising operating cash flow, and a minor tax benefit boost during the second quarter.",0.9593095779418945,0.019256260246038437,0.02143407054245472,positive,0.9400533437728882
28,2018-08-30 07:01:00,"With a trailing P/E around 100, investors are paying a premium for Veeva for three main reasons.",0.1648862361907959,0.03429850563406944,0.8008152842521667,neutral,0.13058772683143616
29,2018-08-30 07:01:00,"First, it's generating impressive double-digit revenue and earnings growth.",0.9338315725326538,0.014550195075571537,0.0516183115541935,positive,0.9192813634872437
30,2018-08-30 07:01:00,"Second, it dominates a high-growth niche within the CRM market with a first-mover's advantage and long-term support from Salesforce.",0.8125524520874023,0.011458820663392544,0.17598874866962433,positive,0.8010936379432678
31,2018-08-30 07:01:00,"Lastly, the healthcare cloud computing market could still expand from $20.2 billion in 2017 to $35 billion by 2022 according to Research and Markets, indicating that Veeva still has plenty of room to grow.",0.9198122024536133,0.012711462564766407,0.06747643649578094,positive,0.9071007370948792
32,2018-08-30 07:01:00,"Therefore, Veeva isn't a stock for queasy investors, but I think it's still one of the best long-term plays in cloud computing.",0.23426640033721924,0.008700435981154442,0.7570331692695618,neutral,0.22556596994400024
33,2018-08-30 07:01:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
34,2018-08-30 07:01:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
35,2018-08-30 07:01:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
36,2018-08-30 07:01:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
37,2018-08-30 07:01:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
38,2018-08-30 07:01:00,Leo Sun owns shares of GlaxoSmithKline.,0.01239218283444643,0.009491105563938618,0.9781167507171631,neutral,0.0029010772705078125
39,2018-08-30 07:01:00,The Motley Fool owns shares of and recommends Salesforce.com and Veeva Systems.,0.03005971759557724,0.018141884356737137,0.9517984390258789,neutral,0.011917833238840103
40,2018-08-30 07:01:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
41,2018-08-30 07:01:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
